0001472595-17-000075.txt : 20170613 0001472595-17-000075.hdr.sgml : 20170613 20170613171127 ACCESSION NUMBER: 0001472595-17-000075 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170612 FILED AS OF DATE: 20170613 DATE AS OF CHANGE: 20170613 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: R1 RCM INC. CENTRAL INDEX KEY: 0001472595 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT SERVICES [8741] IRS NUMBER: 020698101 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 401 NORTH MICHIGAN AVENUE STREET 2: SUITE 2700 CITY: CHICAGO STATE: IL ZIP: 60611 BUSINESS PHONE: 312-324-7820 MAIL ADDRESS: STREET 1: 401 NORTH MICHIGAN AVENUE STREET 2: SUITE 2700 CITY: CHICAGO STATE: IL ZIP: 60611 FORMER COMPANY: FORMER CONFORMED NAME: Accretive Health, Inc. DATE OF NAME CHANGE: 20090918 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RICAURTE CHRISTOPHER SIMON CENTRAL INDEX KEY: 0001483685 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34746 FILM NUMBER: 17909582 MAIL ADDRESS: STREET 1: 5945 AIRPORT ROAD, SUITE 360 CITY: MISSISSAUGA STATE: A6 ZIP: L4V 1R9 4 1 wf-form4_149738827050685.xml FORM 4 X0306 4 2017-06-12 0 0001472595 R1 RCM INC. RCM 0001483685 RICAURTE CHRISTOPHER SIMON C/O R1 RCM INC. 401 N. MICHIGAN AVENUE, SUITE 2700 CHICAGO IL 60611 0 1 0 0 Chief Financial Officer Stock Option (right to buy) 9.3 2017-06-12 4 D 0 200000 D 2023-09-04 Common Stock 200000.0 0 D Stock Option (right to buy) 6.15 2017-06-12 4 D 0 31875 D 2025-01-05 Common Stock 31875.0 0 D Stock Option (right to buy) 3.85 2017-06-12 4 A 0 117671 0 A 2027-06-12 Common Stock 117671.0 117671 D 75% of the cancelled options were vested and immediately exercisable. The unvested portion of the cancelled options would have vested on August 12, 2017. Represents stock options cancelled pursuant to R1 RCM's stock option exchange program as more fully described in the Schedule TO-I, filed with the Securities and Exchange Commission on May 12, 2017 (the "Stock Option Exchange Program"). 50% of the cancelled options were vested and immediately exercisable. The unvested portion of the cancelled options would have vested in 25% increments on January 5, 2018 and 2019. Represents stock options granted pursuant to the Stock Option Exchange Program. The exercise price per share equals the closing price per share of R1 RCM's common stock on June 12, 2017. The options granted in the Stock Option Exchange Program are subject to a two-year vesting period (50% increments on each anniversary of the grant date for two years). /s/ Howard Norber, Attorney-in-Fact 2017-06-13